47 related articles for article (PubMed ID: 15807188)
1. Impact of improving quality of dialysis fluid on oxidative stress and lipid profile in hemodialysis patients.
Elkabbaj D; Bahadi A; Cherrah Y; Errasfa M; Eljaoudi R
ISRN Nephrol; 2013; 2013():717849. PubMed ID: 24967229
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
Mikirova N; Casciari J; Riordan N; Hunninghake R
J Transl Med; 2013 Aug; 11():191. PubMed ID: 23947403
[TBL] [Abstract][Full Text] [Related]
3. Vitamin C Urinary Loss and Deficiency in Human Immunodeficiency Virus (HIV): Cross-sectional Study of Vitamin C Renal Leak in Women With HIV.
Ebenuwa I; Violet PC; Michel K; Padayatty SJ; Wang Y; Tu H; Wilkins KJ; Kassaye S; Levine M
Clin Infect Dis; 2023 Oct; 77(8):1157-1165. PubMed ID: 37264998
[TBL] [Abstract][Full Text] [Related]
4. Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study.
Vollbracht C; Raithel M; Krick B; Kraft K; Hagel AF
J Int Med Res; 2018 Sep; 46(9):3640-3655. PubMed ID: 29950123
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the metabolic properties of maintenance hemodialysis patients with glucose-added dialysis based on high performance liquid chromatography quadrupole time-of-flight mass spectrometry.
Cui L; Meng Y; Xu D; Feng Y; Chen G; Hu B; Feng G; Yin L
Ther Clin Risk Manag; 2013; 9():417-25. PubMed ID: 24194643
[TBL] [Abstract][Full Text] [Related]
6. The Use of High-Dose Intravenous L-Ascorbate in Pain Therapy: Current Evidence from the Literature.
Likar R; Poglitsch R; Bejvančický Š; Carl L; Ferencik M; Klein-Watrycz A; Rieger M; Flores KS; Schumich A; Vlamaki Z; Werner M
Pain Ther; 2024 Jun; ():. PubMed ID: 38864974
[TBL] [Abstract][Full Text] [Related]
7. Excess Ascorbate is a Chemical Stress Agent against Proteins and Cells.
Lehene M; Fischer-Fodor E; Scurtu F; Hădade ND; Gal E; Mot AC; Matei A; Silaghi-Dumitrescu R
Pharmaceuticals (Basel); 2020 May; 13(6):. PubMed ID: 32471171
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?
Liakopoulos V; Roumeliotis S; Bozikas A; Eleftheriadis T; Dounousi E
Oxid Med Cell Longev; 2019; 2019():9109473. PubMed ID: 30774749
[TBL] [Abstract][Full Text] [Related]
9. Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival.
Cimbaljevic S; Suvakov S; Matic M; Pljesa-Ercegovac M; Pekmezovic T; Radic T; Coric V; Damjanovic T; Dimkovic N; Markovic R; Savic-Radojevic A; Simic T
J Med Biochem; 2016 Sep; 35(3):302-311. PubMed ID: 28356881
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of assays for measurement of serum (anti)oxidants in hemodialysis patients.
Ruskovska T; Jansen EH; Antarorov R
Biomed Res Int; 2014; 2014():843157. PubMed ID: 24982909
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
13. Optimal composition of the dialysate, with emphasis on its influence on blood pressure.
Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M
Nephrol Dial Transplant; 2004 Apr; 19(4):785-96. PubMed ID: 15031331
[TBL] [Abstract][Full Text] [Related]
14. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
16. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
